News

1. Balancing Affinity and Safety: Creative Biolabs Strengthens AI-Driven Antibody Engineering

   Recently, Creative Biolabs has been continuously improving its antibody engineering service system based on artificial intelligence.

2. Next-Generation ELISA And Assay Kits For Reliable Biomarker Detection

   Discover high-quality ELISA and assay kits designed for accurate biomarker detection in life science research and diagnostic studies.

3. Softgel Source Establishes Rapid Custom Softgel Prototyping Program in Portland, Oregon to Power U.S. Ingestible Softgel Products Manufacturing Leadership

   Softgel Source, LLC (SGS), today announced its 2026 program for rapid turnaround of low volume, custom ingestible softgels. The program underscores SGS's commitment to advancing U.S.-based manufacturing of ingestible softgels

4. Alfa Cytology Launches Next-Gen PrimePDX™ Platform to Strengthen Preclinical Cancer Modeling from In Vitro to In Vivo

   Alfa Cytology provides in vitro and in vivo models of cancer and Next-Gen PBMC humanized PDX platform for tumor research and immuno-oncology studies.

5. Marquis Who's Who Honors Abderrahman Ouattas, PhD, for Excellence and Outstanding Achievements in Biomechanics and Sensorimotor Neuroengineering

   Abderrahman Ouattas, PhD, brings more than a decade of diverse experience in biomechanics, sensorimotor neuroengineering, and motor control and development to his scientific research and development efforts

6. Alcanza Clinical Research Announces Strategic Acquisition of Tampa Bay Medical Research

   Expanding clinical trial capabilities in Florida through the addition of a long-standing, patient-focused research organization

7. Ace Therapeutics Offers Comprehensive Schizophrenia Animal Model Services to Accelerate Psychiatric Drug Discovery and Development

   Ace Therapeutics announced the commercial launch of its translational mature schizophrenia animal model R&D platform.

8. Creative Biolabs Expands iPSC Services to Support Neuroscience Research

   Creative Biolabs launches its induced pluripotent stem cell (iPSC) services to help researchers obtain more reliable data in neurodegenerative diseases and drug development.

9. CD BioSciences Rolls Out Comprehensive One-Stop Anti-Aging Drug Development Services

   CD BioSciences recently launched a complete one-stop anti-aging drug development service package for pharmaceutical companies, research institutions and academic investigators who are developing cutting-edge anti-aging drugs.

10. Dr. Steven M. Grimes Featured in The Wall Street Journal

    Marquis Who's Who proudly endorsed Dr. Steven M. Grimes in the Central Edition of The Wall Street Journal